Clinical Trial: Decitabine for Poor Graft Function Post Allo-HSCT
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Poor Graft Function
Study Type: INTERVENTIONAL
Official Title: Low Dose Decitabine for Poor Graft Function Post Allogenic Hematopoietic Stem Cell Transplantation
Brief Summary:
This randomized trial aims at validating the efficacy and safety of low-dose decitabine for PGF post allo-HSCT.
Read more